Shannon Marie Beard Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 13455 Se Oatfield Rd Apt 28, Milwaukie, OR 97222 Phone: 541-951-5297 |
Ms. Lindsay Young Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 17070 Se Mcloughlin Blvd, Milwaukie, OR 97267 Phone: 503-594-1772 Fax: 503-594-1773 |
John Lacy Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 4199 Se King Rd, Milwaukie, OR 97222 Phone: 503-786-3830 Fax: 503-653-3534 |
Erik Scholze Counselor Medicare: Not Enrolled in Medicare Practice Location: 11576 Se 27th Ave, Milwaukie, OR 97222 Phone: 503-305-6943 |
Konde Salumu Counselor Medicare: Not Enrolled in Medicare Practice Location: 11576 Se 27th Ave, Milwaukie, OR 97222 Phone: 503-305-6943 |
Asa J Statler Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 13850 Se Autumn Ridge Ter, Milwaukie, OR 97267 Phone: 503-974-9250 Fax: 503-974-9586 |
John Ryan Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 17070 Se Mcloughlin Blvd, Milwaukie, OR 97267 Phone: 503-303-4000 |
Tammy Talbert, MSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 4105 Se International Way, Milwaukie, OR 97222 Phone: 503-740-8787 |
Jeremy Zuercher Counselor Medicare: Not Enrolled in Medicare Practice Location: 11576 Se 27th Ave, Milwaukie, OR 97222 Phone: 503-305-6943 |
Sung Myers Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 4199 Se King Rd, Milwaukie, OR 97222 Phone: 503-786-3830 Fax: 503-653-3534 |
Phil Salina Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2808 Se Balfour St, Milwaukie, OR 97222 Phone: 503-659-2575 Fax: 503-659-5182 |
Katy Brownell Caldwell, B.S., M.A. Counselor Medicare: Not Enrolled in Medicare Practice Location: 3606 Se Lake Rd, Milwaukie, OR 97222 Phone: 503-353-5735 |
Kerrigan Brooke Walsh Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 11458 Se Mceachron Ave, Milwaukie, OR 97222 Phone: 503-305-6286 Fax: 503-387-5279 |
Crystal Crofford Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 13850 Se Autumn Ridge Ter, Milwaukie, OR 97267 Phone: 503-974-9250 Fax: 503-974-9586 |
Emma Stern, MA, PCA R7893 Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 10110 Se Waverly Ct Apt 14, Milwaukie, OR 97222 Phone: 510-730-1789 |
Iris Sobottke Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 11458 Se Mceachron Ave, Milwaukie, OR 97222 Phone: 503-305-6296 Fax: 503-387-5279 |
Eris Egan Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 4545 Se Ina Ave Apt 9, Milwaukie, OR 97267 Phone: 503-654-5678 Fax: 503-654-1236 |
Ben Gernert Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 4545 Se Ina Ave Apt 9, Milwaukie, OR 97267 Phone: 503-654-5678 Fax: 503-654-1236 |
Payton D'ann Lynn Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 13850 Se Autumn Ridge Ter, Milwaukie, OR 97267 Phone: 503-974-9250 Fax: 503-974-9586 |
Catherine Elizabeth Barron, CADC-I, QMHA-R Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 13152 Se Rusk Rd, Milwaukie, OR 97222 Phone: 503-919-7001 |
News Archive
Synergy Pharmaceuticals, Inc. a developer of new drugs to treat gastrointestinal disorders (GI) and diseases, announced today that it has been awarded a $244,479 grant under the Qualifying Therapeutic Discovery Project (QTDP) program to aid the Company in its development of plecanatide currently in clinical development to treat gastrointestinal disorders.
VBL Therapeutics today announced positive results from preclinical and Phase 1 studies evaluating the company's lead anti-cancer agent, VB-111 - a first-in-class, targeted biological agent shown to work via dual-action, anti-angiogenic and vascular disruptive mechanism of action - in metastatic cancer. Preclinical data evaluating VB-111 in a comprehensive set of in vivo studies employing the Lewis Lung metastasis mouse model showed the compound to be safe and specific, with a 90% reduction in tumor burden of lung metastases after only one injection.
As part of its ongoing efforts to make health care safer, the Agency for Healthcare Research and Quality today released a new toolkit to help hospitals prevent catheter-associated urinary tract infections (CAUTIs).
The National Institutes of Health has reported in an Alzheimer's Disease prevention study that there was no increased cardiovascular risk seen in elderly patients taking Celebrex (400 mg daily) for up to three years.
If you want your children to grow up to actively care about the environment, give them plenty of time to play in the "wild" before they're 11 years old, suggests a new Cornell University study.
› Verified 5 days ago